Viridian’s Elegrobart Scores Big Win in Chronic Thyroid Eye Disease Phase 3 Trial – Shares Soar

Viridian's drug for thyroid eye disease showed strong Phase 3 results, improving eye symptoms with simple injections and possible home use.